259 related articles for article (PubMed ID: 455783)
1. ADCC against human erythrocyte target cells: role of the anti-target cell antibodies in determining lymphocyte killer activity.
Nelson DL; Poplack DG; Holiman BJ; Henkart PA
Clin Exp Immunol; 1979 Mar; 35(3):447-53. PubMed ID: 455783
[TBL] [Abstract][Full Text] [Related]
2. The effector cells in human peripheral blood mediating mitogen-induced cellular cytotoxicity and antibody-dependent cellular cytotoxicity.
Nelson DL; Bundy BM; Pitchon HE; Blaese RM; Strober W
J Immunol; 1976 Nov; 117(5 Pt 1):1472-81. PubMed ID: 1087314
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
[TBL] [Abstract][Full Text] [Related]
4. The antibody-dependent cell-mediated cytotoxic (ADCC) reaction. III. Lymphocyte, neutrophil and monocyte cytotoxic activity as a function of the alloantibodies and erythrocyte target cells in the human allogeneic ADCC assay.
Richter M; Richter M; Sklar S
Clin Invest Med; 1983; 6(1):19-24. PubMed ID: 6831791
[TBL] [Abstract][Full Text] [Related]
5. Human antibody-dependent cellular cytotoxicity. Isolation and identification of a subpopulation of peripheral blood lymphocytes which kill antibody-coated autologous target cells.
Brier AM; Chess L; Schlossman SF
J Clin Invest; 1975 Dec; 56(6):1580-6. PubMed ID: 53242
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies against leucoagglutinin-reactive human T lymphocyte surface components. Two antibodies which inhibit cell-mediated cytotoxicity at a post-binding stage.
Vargas-Cortes M; Hammarström ML; Hammarström S; Hellström U; Perlmann P
Eur J Immunol; 1986 Jul; 16(7):795-801. PubMed ID: 3522246
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
Bonavida B; Lebow LT; Bradley TP
J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
[TBL] [Abstract][Full Text] [Related]
8. Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies.
Ortaldo JR; Woodhouse C; Morgan AC; Herberman RB; Cheresh DA; Reisfeld R
J Immunol; 1987 May; 138(10):3566-72. PubMed ID: 2437198
[TBL] [Abstract][Full Text] [Related]
9. The genetic deficiency of leukocyte surface glycoprotein Mac-1, LFA-1, p150,95 in humans is associated with defective antibody-dependent cellular cytotoxicity in vitro and defective protection against herpes simplex virus infection in vivo.
Kohl S; Loo LS; Schmalstieg FS; Anderson DC
J Immunol; 1986 Sep; 137(5):1688-94. PubMed ID: 3528287
[TBL] [Abstract][Full Text] [Related]
10. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.
Moga E; Alvarez E; Cantó E; Vidal S; Rodríguez-Sánchez JL; Sierra J; Briones J
Exp Hematol; 2008 Jan; 36(1):69-77. PubMed ID: 17959301
[TBL] [Abstract][Full Text] [Related]
11. Characterization and utilization of a monoclonal antibody inhibiting porcine natural killer cell activity for isolation of natural killer and killer cells.
Dato ME; Kim YB
J Immunol; 1990 Jun; 144(11):4452-62. PubMed ID: 1971298
[TBL] [Abstract][Full Text] [Related]
12. Chimeric and humanized anti-HM1.24 antibodies mediate antibody-dependent cellular cytotoxicity against lung cancer cells.
Wang W; Nishioka Y; Ozaki S; Jalili A; Verma VK; Hanibuchi M; Abe S; Minakuchi K; Matsumoto T; Sone S
Lung Cancer; 2009 Jan; 63(1):23-31. PubMed ID: 18524412
[TBL] [Abstract][Full Text] [Related]
13. Human bone marrow lymphocytes. Cytotoxic effector cells in the bone marrow of normal individuals.
Fauci AS; Balow JE; Pratt KR
J Clin Invest; 1976 Apr; 57(4):826-35. PubMed ID: 947955
[TBL] [Abstract][Full Text] [Related]
14. In vitro cell-mediated cytotoxicity in primary biliary cirrhosis and chronic hepatitis. Dysfunction of spontaneous cell-mediated cytotoxicity in primary biliary cirrhosis.
Vierling JM; Nelson DL; Strober W; Bundy DM; Jones EA
J Clin Invest; 1977 Nov; 60(5):1116-28. PubMed ID: 332716
[TBL] [Abstract][Full Text] [Related]
15. The antibody-dependent cell-mediated cytotoxic reaction. II. The effect of the concentration of anti-target cell antibodies on the identity of the human effector cells.
Keaney M; McPhail S; Jodouín CA; Richter M
Immunology; 1980 Jun; 40(2):205-10. PubMed ID: 7409857
[TBL] [Abstract][Full Text] [Related]
16. Virus-induced enhancement of lymphocyte-mediated antibody-dependent cytotoxicity (ADCC) in vitro.
Alsheikhly AR; Wåhlin B; Andersson T; Perlmann P
J Immunol; 1984 Jun; 132(6):2760-6. PubMed ID: 6373918
[TBL] [Abstract][Full Text] [Related]
17. Antibody-dependent cellular cytotoxicity against HIV-coated target cells by peripheral blood monocytes from HIV seropositive asymptomatic patients.
Jewett A; Giorgi JV; Bonavida B
J Immunol; 1990 Dec; 145(12):4065-71. PubMed ID: 2258607
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the antibody-dependent cytotoxic capabilities of individual human monocytes. Role of Fc gamma RI and Fc gamma RII and the effects of cytokines at the single cell level.
Connor RI; Shen L; Fanger MW
J Immunol; 1990 Sep; 145(5):1483-9. PubMed ID: 1696598
[TBL] [Abstract][Full Text] [Related]
19. The antibody-independent cytotoxic activity of normal circulating human leucocytes. II. Failure to demonstrate effector cell-target cell interaction and target cell specificity of the circulating cytotoxic-enhancing factor.
Richter M; Banerjee D; Sklar S
Immunology; 1981 Sep; 44(1):109-18. PubMed ID: 6944271
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes.
Neville ME; Hiserodt JC
J Immunol; 1982 Mar; 128(3):1246-51. PubMed ID: 6976989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]